Evidence map›Paper›PMID 30899411›Full record

ArticleAmerican journal of translational research2019

PDCD5 inhibits osteosarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with good prognosis.

Hui Zhao, Changliang Peng, Xinchang Lu, Meng Guo, Tiejun Yang, Junlin Zhou, Yong Hai

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hui ZhaoDepartment of Orthopedics, Beijing Chaoyang Hospital of Capital Medical University Beijing, China.
Changliang PengDepartment of Orthopedics, The Second Hospital of Shandong University Shandong, China.
Xinchang LuDepartment of Orthopedics, The First Hospital of Zhengzhou University Zhengzhou, China.
Meng GuoDepartment of Orthopedics, Beijing Chaoyang Hospital of Capital Medical University Beijing, China.
Tiejun YangDepartment of Orthopedics, Beijing Chaoyang Hospital of Capital Medical University Beijing, China.
Junlin ZhouDepartment of Orthopedics, Beijing Chaoyang Hospital of Capital Medical University Beijing, China.
Yong HaiDepartment of Orthopedics, Beijing Chaoyang Hospital of Capital Medical University Beijing, China.
Beijing Chao-Yang Hospital · CNFirst Affiliated Hospital of Zhengzhou University · CNSecond Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whether programmed cell death 5 (PDCD5) is effective for tumor metastasis remains unclear. In this study, the expression of PDCD5 in 63 osteosarcoma (OS) tissues and two OS cell lines was analyzed. Then the relationship between PDCD5 expression and clinicopathological features of OS was studied. In addition, adhesion, wound healing, Transwell and Matrigel tube formation assays were used to explore the role of PDCD5 in OS cell adhesion, migration, invasion and angiogenesis. Western blotting was used to detect the protein expression of TGF-β1/Smad signaling pathway and epithelial-mesenchymal transition (EMT)-related markers. At the same time, key molecules involved in migration, invasion and EMT in tumor specimens were assessed by immunohistochemistry. The data showed that PDCD5 overexpression significantly attenuated OS cell adhesion, migration, invasion and angiogenesis. Furthermore, PDCD5 knockdown caused an opposite effect on these phenotypes

Indexed as

EMTinvasionmetastasisosteosarcomaPDCD5TGF-β1

Identifiers

PMID30899411
PMCPMC6413283
OpenAlexW3016136112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.